Stifel Maintains Buy on Edwards Lifesciences, Raises Price Target to $100

Benzinga · 2d ago
Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $95 to $100.